Definitive Contract 140D0426C0135
Award Date 9/9/26
Potential Completion Date 9/14/28
Potential Value $3M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92127, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract for $248,077.00 awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Electronic Biosciences, Inc., a for-profit organization located in San Diego, CA. The contract is for the development of nanoscale tools for RNA modification sequencing. Electronic Biosciences has previously received federal grants and contracts from...
- This is a $299,999.00 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Electronic Biosciences, Inc., a small business. The contract is for the ALTERNATING-SEQ (MOONSHOT) requirement, which has a firm fixed price pricing structure and a completion date of March 16, 2020. Electronic Biosciences has prior experience providing goods and services such as nanopore platforms, temperature-controlled systems,...
- This federal contract award was made by the National Institute of Standards and Technology (NIST), a civilian agency, to Electronic Biosciences, Inc., a small business biotechnology company. The $299,973.23 contract is a Small Business Innovation Research (SBIR) Phase II award under the American Recovery and Reinvestment Act (ARRA) to fund the development of Electronic Biosciences' advanced nanopore-based sequencing and analytical technologies. This definitive, firm-fixed price contract supports...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
- <p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on December 21, 2018, valued at $23,555.00, with completion set for January 31, 2019. Work is performed in Menlo Park, California. The order procures DNA and RNA sequencing technologies and associated consumables on a firm fixed-price basis with no small business set-aside.</p>
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $346,907.40 on July 8, 2026, for sequencing reagents and SMRT cells compatible with the Revio platform. The procurement was set aside for total small business and carries a firm-fixed-price structure with completion scheduled for July 7, 2027. Work is performed in Menlo Park, California. The requirement stems from a total small business sole-source procurement (Contract...
- <p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. valued at $345,390 on August 12, 2026, for next-generation sequencing consumables including PromethION flow cell packs (RNA and DNA), Direct RNA sequencing and barcoding kits, and Ultra-Long and Ligation DNA sequencing kits. Performance occurs in New York, New York, with ultimate completion by August 11, 2027. The order carries firm fixed pricing and no set-aside designation.</p>
- This contract award to Pacific Biosciences of California, Inc. is for the delivery of a PacBio RS II DNA Sequencer System to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $627,500 firm-fixed-price contract has a completion date of July 31, 2014. As the original equipment manufacturer, Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to federal agencies. The company has been...